SPA
COLL icon

Sherbrooke Park Advisers’s Collegium Pharmaceutical COLL Stock Holding History

Sherbrooke Park Advisers’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-7,737
Closed -$231K – 557
2025
Q1 		$231K Buy
+7,737
New +$236K 0.11% 386
2024
Q3 		– Sell
-18,990
Closed -$611K – 962
2024
Q2 		$611K Buy
+18,990
New +$658K 0.11% 328

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Sherbrooke Park Advisers's COLL Position: Q2 2025 in Review

Sherbrooke Park Advisers sold out of Collegium Pharmaceutical (COLL) in Q2 2025, closing a stake of 7,737 shares — an estimated $231K sold.

Sherbrooke Park Advisers first reported a position in COLL in Q2 2024 and held it in 2 quarters. The position peaked at $611K in Q2 2024. 223 funds tracked by Wall St. Rank hold COLL as of Q2 2025.

  • Sherbrooke Park Advisers reported no remaining Collegium Pharmaceutical position as of Q2 2025 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 7,737 Collegium Pharmaceutical shares in Q2 2025, an estimated $231K.
  • Sherbrooke Park Advisers first reported a position in Collegium Pharmaceutical in Q2 2024 and held it in 2 quarters.
  • Sherbrooke Park Advisers's Collegium Pharmaceutical position peaked at $611K in Q2 2024.
  • 223 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.